Seizert Capital Partners LLC Acquires 84,096 Shares of The Cigna Group (NYSE:CI)

Seizert Capital Partners LLC increased its holdings in The Cigna Group (NYSE:CI - Free Report) by 203.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 125,529 shares of the health services provider's stock after acquiring an additional 84,096 shares during the period. The Cigna Group makes up about 2.0% of Seizert Capital Partners LLC's holdings, making the stock its 18th largest holding. Seizert Capital Partners LLC's holdings in The Cigna Group were worth $43,488,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Cedar Wealth Management LLC purchased a new position in shares of The Cigna Group during the 1st quarter worth approximately $29,000. TruNorth Capital Management LLC acquired a new position in The Cigna Group during the 2nd quarter worth about $33,000. Ulland Investment Advisors LLC lifted its stake in The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider's stock worth $36,000 after acquiring an additional 100 shares in the last quarter. Harbor Capital Advisors Inc. purchased a new position in The Cigna Group during the 3rd quarter valued at about $45,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in The Cigna Group in the 2nd quarter valued at about $66,000. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Stock Performance

Shares of NYSE:CI traded down $2.36 during trading hours on Friday, hitting $321.52. The stock had a trading volume of 1,650,180 shares, compared to its average volume of 2,250,354. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $370.83. The stock's fifty day simple moving average is $338.88 and its 200 day simple moving average is $339.55. The firm has a market capitalization of $89.43 billion, a price-to-earnings ratio of 30.33, a PEG ratio of 0.97 and a beta of 0.51.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion for the quarter, compared to analysts' expectations of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm's revenue was up 29.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.77 earnings per share. Sell-side analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be given a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.74%. The Cigna Group's payout ratio is presently 52.83%.

Insider Buying and Selling at The Cigna Group

In other news, Director William J. Delaney III sold 2,691 shares of the firm's stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the sale, the director now directly owns 17,539 shares of the company's stock, valued at $6,010,264.52. This trade represents a 13.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.60% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Royal Bank of Canada dropped their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Jefferies Financial Group upped their price objective on The Cigna Group from $402.00 to $422.00 and gave the stock a "buy" rating in a research report on Tuesday, September 17th. StockNews.com lowered The Cigna Group from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. JPMorgan Chase & Co. increased their price target on The Cigna Group from $435.00 to $438.00 and gave the company an "overweight" rating in a research report on Wednesday, August 21st. Finally, Barclays boosted their price objective on The Cigna Group from $405.00 to $420.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, The Cigna Group currently has an average rating of "Buy" and a consensus price target of $394.64.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.